115 related articles for article (PubMed ID: 10428529)
1. The effect of oestrogen supplementation on post-menopausal urinary stress incontinence: a double-blind placebo-controlled trial.
Jackson S; Shepherd A; Brookes S; Abrams P
Br J Obstet Gynaecol; 1999 Jul; 106(7):711-8. PubMed ID: 10428529
[TBL] [Abstract][Full Text] [Related]
2. The effect of oestradiol on vaginal collagen metabolism in postmenopausal women with genuine stress incontinence.
Jackson S; James M; Abrams P
BJOG; 2002 Mar; 109(3):339-44. PubMed ID: 11950190
[TBL] [Abstract][Full Text] [Related]
3. The effect of oestrogen supplementation on postmenopausal urinary stress incontinence: a double-blind placebo-controlled trial.
Dickson MJ; Salleh S
BJOG; 2000 Mar; 107(3):433-4. PubMed ID: 10740346
[No Abstract] [Full Text] [Related]
4. Treatment with oral piperazine oestrone sulphate for genuine stress incontinence in postmenopausal women.
Wilson PD; Faragher B; Butler B; Bu'Lock D; Robinson EL; Brown AD
Br J Obstet Gynaecol; 1987 Jun; 94(6):568-74. PubMed ID: 3113475
[TBL] [Abstract][Full Text] [Related]
5. Oestrogen versus androgen in hormone-replacement therapy for complete androgen insensitivity syndrome: a multicentre, randomised, double-dummy, double-blind crossover trial.
Birnbaum W; Marshall L; Werner R; Kulle A; Holterhus PM; Rall K; Köhler B; Richter-Unruh A; Hartmann MF; Wudy SA; Auer MK; Lux A; Kropf S; Hiort O
Lancet Diabetes Endocrinol; 2018 Oct; 6(10):771-780. PubMed ID: 30075954
[TBL] [Abstract][Full Text] [Related]
6. Effects of oestradiol and combined norephedrin and oestradiol treatment on female stress incontinence.
Ek A; Andersson KE; Gullberg B; Ulmsten U
Zentralbl Gynakol; 1980; 102(15):839-44. PubMed ID: 7006273
[TBL] [Abstract][Full Text] [Related]
7. Oestrogens for urinary incontinence in women.
Moehrer B; Hextall A; Jackson S
Cochrane Database Syst Rev; 2003; (2):CD001405. PubMed ID: 12804406
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, placebo controlled study of postmenopausal oestrogen replacement therapy and carotid artery pulsatility index.
Jackson S; Vyas S
Br J Obstet Gynaecol; 1998 Apr; 105(4):408-12. PubMed ID: 9609267
[TBL] [Abstract][Full Text] [Related]
9. [Ultrasound imaging of the lower urinary tract in post-menopausal women with urinary stress or combined type of incontinence before and after intravaginal administration of estriol].
Martan A; Masata J; Halaska M; Voigt R
Ceska Gynekol; 1999 Jan; 64(1):6-9. PubMed ID: 10377583
[TBL] [Abstract][Full Text] [Related]
10. Measurement of urethral closure function in women with stress urinary incontinence.
Klarskov N; Scholfield D; Soma K; Darekar A; Mills I; Lose G
J Urol; 2009 Jun; 181(6):2628-33; discussion 2633. PubMed ID: 19375093
[TBL] [Abstract][Full Text] [Related]
11. Double-blind, placebo-controlled, hormonal, syndromal and EEG mapping studies with transdermal oestradiol therapy in menopausal depression.
Saletu B; Brandstätter N; Metka M; Stamenkovic M; Anderer P; Semlitsch HV; Heytmanek G; Huber J; Grünberger J; Linzmayer L
Psychopharmacology (Berl); 1995 Dec; 122(4):321-9. PubMed ID: 8657828
[TBL] [Abstract][Full Text] [Related]
12. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
Prescrire Int; 2004 Jun; 13(71):106-9. PubMed ID: 15233153
[TBL] [Abstract][Full Text] [Related]
13. Prospective multicentre randomised trial of tension-free vaginal tape and colposuspension as primary treatment for stress incontinence.
Ward K; Hilton P;
BMJ; 2002 Jul; 325(7355):67. PubMed ID: 12114234
[TBL] [Abstract][Full Text] [Related]
14. The use of intravaginal oestrogen cream in genuine stress incontinence.
Hilton P; Stanton SL
Br J Obstet Gynaecol; 1983 Oct; 90(10):940-4. PubMed ID: 6313035
[TBL] [Abstract][Full Text] [Related]
15. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial.
Khullar V; Hill S; Laval KU; Schiøtz HA; Jonas U; Versi E
Urology; 2004 Aug; 64(2):269-74; discussion 274-5. PubMed ID: 15302476
[TBL] [Abstract][Full Text] [Related]
16. Phenylpropanolamine in treatment of female stress urinary incontinence. Double-blind placebo controlled study in 24 patients.
Collste L; Lindskog M
Urology; 1987 Oct; 30(4):398-403. PubMed ID: 3310369
[TBL] [Abstract][Full Text] [Related]
17. Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double-blind, placebo-controlled EIGHT trial.
Chapple C; Schneider T; Haab F; Sun F; Whelan L; Scholfield D; Dragon E; Mangan E
BJU Int; 2014 Sep; 114(3):418-26. PubMed ID: 24552358
[TBL] [Abstract][Full Text] [Related]
18. Continuous transdermal oestrogen and interrupted progestogen as a novel bleed-free regimen of hormone replacement therapy for postmenopausal women.
Cameron ST; Critchley HO; Glasier AF; Williams AR; Baird DT
Br J Obstet Gynaecol; 1997 Oct; 104(10):1184-90. PubMed ID: 9332998
[TBL] [Abstract][Full Text] [Related]
19. Menopausal genuine stress urinary incontinence treated with conjugated estrogens plus progestogens.
Sartori MG; Baracat EC; Girão MJ; Gonçalves WJ; Sartori JP; de Lima GR
Int J Gynaecol Obstet; 1995 May; 49(2):165-9. PubMed ID: 7649322
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of PSD503 (phenylephrine 20%, w/w) for topical application in women with stress urinary incontinence. A phase II, multicentre, double-blind, placebo controlled, 2-way cross over study.
Robinson D; Abrams P; Cardozo L; Ellis-Jones J; Heath P; Wyllie M
Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):457-60. PubMed ID: 21831512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
